These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36450973)

  • 1. Cilostazol in Cerebral Ischemia and Subarachnoid Hemorrhage: A Promising Agent as Prevention.
    Aspide R; Castioni CA
    Neurocrit Care; 2023 Feb; 38(1):7-8. PubMed ID: 36450973
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Cilostazol in Animal Models of Cerebral Ischemia and Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
    Qureshi AI; Akhtar IN; Ma X; Lodhi A; Bhatti I; Beall J; Broderick JP; Cassarly CN; Martin RH; Sharma R; Thakkar M; Suarez JI
    Neurocrit Care; 2023 Jun; 38(3):698-713. PubMed ID: 36450971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol may prevent cerebral vasospasm following subarachnoid hemorrhage.
    Yoshimoto T; Shirasaka T; Fujimoto S; Yoshidumi T; Yamauchi T; Tokuda K; Kaneko S; Kashiwaba T
    Neurol Med Chir (Tokyo); 2009 Jun; 49(6):235-40; discussion 240-1. PubMed ID: 19556731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shan T; Zhang T; Qian W; Ma L; Li H; You C; Xie X
    J Neurol; 2020 Jun; 267(6):1577-1584. PubMed ID: 30739182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Dependent Inhibitory Effects of Cilostazol on Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage.
    Suzuki H; Nakatsuka Y; Yasuda R; Shiba M; Miura Y; Terashima M; Suzuki Y; Hakozaki K; Goto F; Toma N
    Transl Stroke Res; 2019 Aug; 10(4):381-388. PubMed ID: 30033486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol Administration for Subarachnoid Hemorrhage: A Meta-analysis of Randomized Controlled Trials.
    Chen H; Luo W; Cai X; Cai J
    Clin Neuropharmacol; 2022 Sep-Oct 01; 45(5):111-116. PubMed ID: 36162042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report.
    Suzuki S; Sayama T; Nakamura T; Nishimura H; Ohta M; Inoue T; Mannoji H; Takeshita I
    Cerebrovasc Dis; 2011; 32(1):89-93. PubMed ID: 21677432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cilostazol treatment for patients with aneurysmal subarachnoid hemorrhage: A meta-analysis of 14 studies.
    Li L; Fu X; Qiu H; Shi P
    J Clin Neurosci; 2022 May; 99():190-203. PubMed ID: 35286971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage.
    Sugimoto K; Nomura S; Shirao S; Inoue T; Ishihara H; Kawano R; Kawano A; Oka F; Suehiro E; Sadahiro H; Shinoyama M; Oku T; Maruta Y; Hirayama Y; Hiyoshi K; Kiyohira M; Yoneda H; Okazaki K; Dreier JP; Suzuki M
    Ann Neurol; 2018 Dec; 84(6):873-885. PubMed ID: 30341966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
    Bohara S; Garg K; Singh Rajpal PM; Kasliwal M
    World Neurosurg; 2021 Jun; 150():161-170. PubMed ID: 33631387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol reduces morbidity but not mortality secondary to cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Ding D
    J Neurol Sci; 2014 May; 340(1-2):243-4. PubMed ID: 24690347
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage].
    Murahashi T; Kamiyama K; Hara K; Ozaki M; Mikamoto M; Nakagaki Y; Nakagaki Y; Nakamura H
    No Shinkei Geka; 2013 May; 41(5):393-400. PubMed ID: 23648655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging.
    Ito H; Fukunaga M; Suzuki H; Miyakoda G; Ishikawa M; Yabuuchi Y; Taki W
    Neurobiol Dis; 2008 Oct; 32(1):157-61. PubMed ID: 18675358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].
    Ishiguro M; Hara H
    Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol administration for subarachnoid hemorrhage: A meta-analysis of randomized controlled trials.
    Chen J; Tang P; Fu X
    J Clin Neurosci; 2021 Jul; 89():305-310. PubMed ID: 34119285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    Nishino A; Umegaki M; Fujinaka T; Yoshimine T
    Neurol Res; 2010 Oct; 32(8):873-8. PubMed ID: 20350366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.